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p53Genome-wide association studies have linked LRP8 polymorphisms to premature coronary artery disease
and myocardial infarction in humans. However, the mechanisms by which dysfunctions of apolipoprotein E
receptor-2 (apoER2), the protein encoded by LRP8 gene, inﬂuence atherosclerosis have not been elucidated
completely. The current study focused on the role of apoER2 inmacrophages, a cell type that plays an important
role in atherosclerosis. Results showed that apoER2-deﬁcient mouse macrophages accumulated more lipids and
were more susceptible to oxidized LDL (oxLDL)-induced death compared to control cells. Consistent with these
ﬁndings, apoER2 deﬁcient macrophages also displayed defective serum-induced Akt activation and higher levels
of the pro-apoptotic protein phosphorylated p53. Furthermore, the expression and activation of peroxisome
proliferator-activated receptor γ (PPARγ) were increased in apoER2-deﬁcient macrophages. Deﬁciency of
apoER2 in hypercholesterolemic LDL receptor-null mice (Lrp8−/−Ldlr−/−mice) also resulted in accelerated
atherosclerosis with more complex lesions and extensive lesion necrosis compared to Lrp8+/+Ldlr−/−mice.
The atherosclerotic plaques of Lrp8−/−Ldlr−/− mice displayed signiﬁcantly higher levels of p53-positive
macrophages, indicating that the apoER2-deﬁcient macrophages contribute to the accelerated atherosclerotic
lesionnecrosis observed in these animals. Taken together, this study indicates that apoER2 inmacrophages limits
PPARγ expression and protects against oxLDL-induced cell death. Thus, abnormal apoER2 functions in macro-
phages may at least in part contribute to the premature coronary artery disease and myocardial infarction in
humans with LRP8 polymorphisms. Moreover, the elevated PPARγ expression in apoER2-deﬁcient macrophages
suggests that LRP8 polymorphism may be a genetic modiﬁer of cardiovascular risk with PPARγ therapy.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Genome-wide linkage studies have shown the association of a single
nucleotide polymorphism (SNP) in the LRP8 genewith thedevelopment
of familial and premature coronary artery disease (CAD) andmyocardial
infarction in humans [1,2]. This LRP8 SNP is also additive with APOE
genotype, an established genetic risk factor for CVD, in modulatingter A1; ApoA-I, apolipoprotein
eceptor-2; CVD, cardiovascular
rum; HDL, high density lipopro-
lipoprotein receptor; oxLDL,
oliferator-activated receptor γ;
CR, quantitative real-time PCR;
and Laboratory Medicine (ML
0 E. Galbraith Road, Cincinnati,
1312.
Regents University, Augusta,myocardial infarction risk [3]. Four additional LRP8 SNPs have also
been identiﬁed as risk factors for familial and premature CAD andmyo-
cardial infarction while a haplotype carrying protective alleles from
these ﬁve LRP8 SNPs has been shown to confer protection against CAD
and myocardial infarction in humans [4]. These studies suggest that
apolipoprotein E receptor-2 (apoER2) encoded by the LRP8 gene may
play an important role in atherosclerosis development and progression.
The apolipoprotein E receptor-2 (gene name: LDL receptor-related
protein-8, LRP8) is a type 1 transmembrane protein structurally similar
to other LDL receptor family proteins, with an extracellular domain
composed of multiple cysteine-rich ligand binding repeats, a single
transmembrane domain and a short cytoplasmic tail that includes
several adaptor protein binding motifs. ApoER2 was ﬁrst identiﬁed
as a novel LDL receptor family protein expressed predominantly in the
brain [5]; hence its role in brain development and its function in main-
taining synaptic plasticity and memory are best characterized. In the
developmental stage, apoER2 is critical for the ordered formation of
cortical layers [6], whereas apoER2 activity is required in the adult
brain for long term potentiation as well as maintenance of normal
Table 1
Primer sequences used for quantitative real-time PCR analysis of RNA.
Gene name Primer sequence
Abca1 Sense 5′-ACCCACCCTACGAACAACATGAGT-3′
Antisense 5′-AAAGTTTCCAACAACACCGGGAGC-3′
Cd36 Sense 5′-CTGTTATTGGTGCAGTCCTGGC-3′
Antisense 5′-TATGTGGTGCAGCTGCTACAGC-3′
Gapdh Sense 5′-GGTGTGAACGGATTTGGCCGTATT-3′
Antisense 5′-GGTCGTTGATGGCAACAATCTCCA-3′
Lrp1 Sense 5′-CTGAAGGGCTTTGTGGATGAGCATAC-3′
Antisense 5′-GTAGAAGTTTCCCGTCAGCCAGTC-3′
Lrp8 (apoER2) Sense 5′-TCATCGTGCCCATAGTGGTAATAG-3′
Antisense 5′-TTGGTGTTCTTCCGCTTCCAGTTC-3′
Msr1 (SRA) Sense 5′-TTCAAGGCTGCCCTCATT-3′
Antisense 5′-AAGCTGAGCTGTTACTATTCCA-3′
Olr1 (Lox1) Sense 5′-GAAATCCAAAGAGCAGGAGGAG-3′
Antisense 5′-CTTGTGGACAAGGACCTGAAA-3′
Pparg (PPARγ) Sense 5′-CTGCAGGCCCTGGAACTG-3′
Antisense 5′-CGATCTGCCTGAGGTCTGTCA-3′
Fig. 1.Generation of Lrp8 deﬁcientmacrophages. (A) Lrp8mRNA expression levels in peri-
toneal macrophages (MPM) isolated from Lrp8+/+ (black bars) and Lrp8−/− (white bars)
mice, non-transduced control RAW 264.7 cells (black bars), RAW 264.7 cells transduced
with an empty vector (gray bars), and RAW 264.7 cells with Lrp8 knocked down (white
bars) normalized to the expression of the housekeeping gene Gapdh. (B) Levels of
apoER2 protein in non-transduced control RAW 264.7 cells, RAW 264.7 cells transduced
with an empty vector (EV), and RAW 264.7 cells with Lrp8 knocked down (KD) normal-
ized to expression of the tubulin loading control. Inset shows representative immunoblots.
MPM n=5 per group, RAW264.7mRNA n=9 per group, RAW264.7 control and knock-
down protein n= 6 per group, RAW 264.7 empty vector protein n= 9. Data represent
mean ± SEM, * denotes P ≤ 0.05 difference from Lrp8+/+/non-transduced control RAW
264.7 cells, and † denotes P b 0.05 difference from empty vector-transfected RAW 264.7
cells.
1396 M.D. Waltmann et al. / Biochimica et Biophysica Acta 1842 (2014) 1395–1405behavior [7]. ApoER2 present in the adult postsynaptic densities of
excitatory synapses forms a functional complex with NMDA receptors
and is required for normal synaptic neurotransmission and memory
[8]. Interestingly, apoER2 is also required for protection against neuro-
nal cell loss during normal aging, but selectively promotes neuronal
cell death after injury [9]. These data indicate that apoER2 is required
for brain development as well as in the control of neuronal aging and
survival after injury in adult brain.
In addition to its predominant expression in the brain, apoER2 is also
abundantly expressed in testis where its activity in mediating selenium
uptake is critical for male fertility [10,11]. Although expressed at lower
levels, apoER2 is also present in cells that participate in atherosclerosis
pathogenesis including platelets [12–14], endothelial cells [15–17],
and monocytes/macrophages [18,19]. In platelets, apoE binding
to apoER2 stimulates nitric oxide synthesis and as a result inhibits
agonist-induced platelet activation in vitro [14,20]. The platelet
apoER2 is also known to modulate adhesion and bleeding time in vivo
[21]. In endothelial cells, apoE binding to apoER2 also stimulates
nitric oxide synthesis and inhibits vascular cell adhesion molecule-
1 (VCAM-1) expression [16,22]. However, apoER2 on platelets and
endothelial cells also interacts with β2-glycoprotein I–antibody
complex [23,24] and mediates leukocyte–endothelial cell adhesion
and thrombosis induced by antiphospholipid antibodies through
inhibition of endothelial nitric oxide synthase [17].
The functional signiﬁcance of apoER2 expression in monocytes/
macrophages is less clear. In cell culture studies with the U937
human monocytic cells, apoER2 was shown to be one of the recep-
tors in binding activated protein C, leading to activation of the Akt
pathway to suppress endotoxin induced procoagulant activity [18].
Additionally, over-expression of apoER2 in RAW 264.7 mouse macro-
phages has also been reported to increase reelin- and apoE-induced
ABCA1 expression and cholesterol efﬂux, whereas knockdown of
apoER2 expression ameliorated the reelin and apoE effects [19].
While these data suggest that apoER2 expression in monocytes/
macrophages may beneﬁt atherosclerosis and prevent lipid accumu-
lation, knockdown of apoER2 expression in RAW 264.7 cells had no
effect on ABCA1 expression level in the absence of apoE or reelin [19].
Thus, whether apoER2 expression modulates macrophage functions
independent of reelin and apoE binding, and its impact on atherosclero-
sis progression remain unknown. This studywas undertaken to address
these issues.
2. Materials and methods
2.1. Cell culture
Primary mouse macrophages were isolated from the peritoneum of
age-matched Lrp8+/+ and Lrp8−/− mice maintained on a chow diet
4 days after injection of sterile 4% thioglycollate solution into their
peritoneal cavities. The isolated cells were allowed to adhere to tissue
culture plates for at least 4 h and then washed vigorously with sterile
PBS to remove non-adherent cells. The adhering mouse peritoneal
macrophages were cultured in RPMI-1640 medium (Thermo Scientiﬁc,
Florence, KY, USA) containing 10% endotoxin-free fetal bovine serum
(FBS, Invitrogen, Grand Island, NY, USA), 100 units/ml penicillin
100 μg/ml streptomycin solution (Thermo Scientiﬁc), and 2 mM
L-glutamine (Thermo Scientiﬁc) at 37 °C and 5% CO2 unless noted
otherwise. Cell counts were performed manually by trypan blue exclu-
sion. The peritoneal macrophages were harvested for further analysis
within 4 days of isolation. The mouse macrophage cell line RAW 264.7
cells (ATCC,Manassas, VA, USA)were also cultured under similar condi-
tions. Phosphorylated Akt and total Akt protein levels were assessed in
whole cell lysates obtained from RAW 264.7 cells that were seeded at
equal densities, allowed to adhere for 16 h overnight, replaced with
serum-freemedia for 24 h, and then returned to freshmedia containing
10% FBS for the indicated time.2.2. Inactivation of Lrp8 gene expression in RAW 264.7 cells
Five lentiviral transduction particles in pLKO.1 vectors expressing
shRNA that target the mouse Lrp8 gene were obtained from Sigma-
Aldrich (St. Louis, MO, USA). These lentiviral vectors (identiﬁcation
numbers: TRCN0000176508, TRCN0000177833, TRCN0000178706,
TRCN0000176636, TRCN0000177656) were added to RAW 264.7 cells
in culture medium containing 8 μg/ml hexadimethrine bromide at a
multiplicity of infection of 1 for a total multiplicity of infection of 5.
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allowed to recover in fresh culturemedium for 24 h. Following puromy-
cin (2–10 μg/ml) selection for 1–2 weeks, the cells were returned to
basal medium and were occasionally cultured in the presence of puro-
mycin in order to maintain selection of transduced cells. The transduc-
tion was veriﬁed based on lack of Lrp8 mRNA and apoER2 protein as
assessed by quantitative real-time PCR and Western blot analysis,
respectively. Similarly, RAW 264.7 cells were also transduced with
lentiviral particles containing an empty vector (MISSION™ pLKO.1-
puro control transduction particles #SHC001V) as a control. All cells
were cultured in the absence of puromycin for at least 1 week prior to
performing all experiments.2.3. Quantitative real-time PCR
Total RNA was isolated from mouse peritoneal macrophages and
RAW 264.7 cells with the RNeasy® Plus Mini Kit (Qiagen, Valencia, CA,
USA) and the RNeasy® Mini Kit (Qiagen), respectively. Genomic DNA
was removed by treatment with TURBO DNA-free™ (Ambion, Austin,
TX, USA). The RNA was then quantiﬁed by measuring the absorbance
at 260 nm. The cDNAwas synthesized using the iScript™ cDNASynthesis
Kit (Bio-Rad Laboratories, Hercules, CA, USA) and quantitative real-timeFig. 2.Neutral lipid accumulation inmacrophages lacking apoER2. (A) Non-transduced control
vector (gray bars), andRAW264.7 cellswith Lrp8 knocked down (open histograms, KD,white b
were then analyzed for neutral lipid accumulation by staining with HCS LipidTOX Green Neutr
(MFI) of the cells was determined by analysis of histograms. Top panels show representative his
RAW 264.7 cells. RAW 264.7 empty vector n=6, RAW 264.7 non-transduced control and knoc
≤ 0.05 difference. (B) mRNA levels of CD36,Msr1, and Olr1 relative to Gapdh in non-transduced
transduced RAW264.7 cells. Data represent mean ± SEM from n= 9 per group. * denotes P b
empty vector transfected RAW 264.7 cells. (C) Non-transduced control RAW264.7 cells (Con
shRNA (KD, white bars) were incubated with [3H]cholesteryl oleate-containing acetylated L
apoA-I to facilitate cholesterol efﬂux. Data are reported as the mean ± SEM percentage of tota
letters denote P b 0.05 differences.PCR was performed on an iQ™ 4 iCycler (Bio-Rad) using the iQ™
SYBER® Green Supermix (Bio-Rad) and the sequence speciﬁc primers
(Table 1). The mRNA expression levels relative to the expression of the
Gapdhhousekeeping genewere calculatedusing theΔCTqPCRdata anal-
ysis method.2.4. Immunoblot analysis
Whole cell lysates were prepared in RIPA buffer containing 0.05 M
Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% sodium deoxycholate, 1% igepal,
0.1% SDS, 1 mM EDTA, 1× phosphatase inhibitor cocktail 2 (Sigma-
Aldrich), 1× phosphatase inhibitor cocktail 3 (Sigma-Aldrich), and
1× complete protease inhibitor cocktail (Roche Applied Science,
Indianapolis, IN, USA). Nuclear protein extracts were isolated for
PPARγ immunoblots from cultured cells using the Nuclear Extraction
Kit (Cayman Chemicals, Ann Arbor, MI, USA). The protein concentra-
tions were determined using the Pierce® BCA Protein Assay Kit (Ther-
mo Scientiﬁc). Equal amounts of the protein samples were resolved in
10% SDS–polyacrylamide gels in the presence of dithiothreitol (DTT)
and were then transferred to Immun-blot PVDF membrane (Bio-Rad).
The membranes were blocked with buffer containing 0.1% Tween-20
and 5% nonfat dry milk for 1 h at room temperature. Primary antibodyRAW264.7 cells (ﬁlled histograms, black bars), RAW264.7 cells transducedwith an empty
ars)were incubated in the presence or absence (NT) of 50 μg/ml oxLDL overnight. The cells
al Lipid Stain and subsequent ﬂow cytometry analysis. The median ﬂuorescence intensity
tograms generated by ﬂow cytometry analysis of non-transduced control and knockdown
kdown n= 3 per group. Data represent mean ± SEM. Bars with different letters denote P
control (Con, black bars), empty vector (EV, gray bars), and Lrp8 shRNA (KD, white bars)
0.05 difference from non-transduced control cells, and † denotes P b 0.05 difference from
, black bars) and RAW264.7 cells transduced with empty vector (EV, gray bars) or Lrp8
DL overnight, followed by incubation in the absence (NT) or presence of HDL, apoE, or
l radioactivity found in the incubation medium from n= 3 per group. Bars with different
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incubations were performed for 1 h at room temperature. The primary
antibodies used were anti-Lrp8 (Sigma-Aldrich), anti-phospho-Akt
(Serine 473, Cell Signaling Technology, Boston, MA), anti-Akt (Cell
Signaling Technology), anti-phospho-p53 (Serine 15, Cell Signaling
Technology), anti-p53 (Cell Signaling Technology), anti-PPARγ (Cell
Signaling Technology), anti-TATA binding protein (TBP, Cell Signaling
Technology), and anti-tubulin (Fisher Scientiﬁc, Abcam). The secondary
antibodies used were HRP-linked anti-rabbit IgG (Cell Signaling Tech-
nology), HRP-linked anti-mouse IgG (Cell Signaling Technology), HRP-
linked anti-rat IgG (Sigma-Aldrich), and HRP-linked anti-goat IgG
(Dako, Carpinteria, CA). Immunoreactive bands were visualized by
chemiluminescence using Pierce® ECL Western Blotting SubstrateFig. 3.Oxidized LDL-induced death in control and apoER2 deﬁcientmacrophages. Non-transduc
(gray bars), and RAW264.7 cells with Lrp8 knocked down (white bars)were incubated overnig
propidium iodide and analyzed by ﬂow cytometry. Top panels show representative dot plots ge
age of Annexin-V positive pre-apoptotic cells (A+/PI−) and Annexin-V and propidium iodide
from n= 9 RAW 264.7 empty vector group, and n= 6 from RAW 264.7 non-transduced and
† denotes P b 0.05 difference from empty vector cells.(Thermo Scientiﬁc) and an Amersham™ ECL Advance™ Western
Blotting Detection Kit (GE Healthcare, Pittsburgh, PA, USA). Densitome-
try analysis was performed with digitalized images using ImageJ soft-
ware (NIH, Bethesda, MD, USA).2.5. Oxidation of LDL
Preparative ultracentrifugal ﬂotation in KBr solutions between the
densities of 1.02 and 1.063 m/ml was used to isolated human LDL
from fresh plasma. The isolated LDL was incubated at 37 °C with
12.5 μM CuSO4 overnight and then dialyzed exhaustively against saline
solution. The oxidation status of the copper-oxidized LDL was betweened control RAW264.7 cells (black bars), RAW264.7 cells transducedwith an empty vector
htwith 500 μg/ml oxLDL. The cells were then stainedwith APC-conjugated Annexin-V and
nerated by ﬂow cytometry analysis. Regionmarkers were applied to quantify the percent-
positive dead cells (A+/PI+) in the populations. The bottom panels show mean ± SEM
knockdown groups. * denotes P b 0.05 difference from non-transduced control cells, and
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measuring thiobarbituric acid reactive substance (TBARS).
2.6. In vitro neutral lipid accumulation
Cells were seeded at equal densities and incubated overnight in the
presence or absence of 50 μg/ml copper-oxidized human LDL. Incuba-
tions were performed in media without FBS that contained 5% human
lipoprotein deﬁcient serum. Following the overnight incubation, cells
were harvested and stained with HCS LipidTOX Green Neutral Lipid
Stain (Invitrogen). Flow cytometry analysis was performed using a
Guava easyCyte™ 8HT system (Millipore, Billerica, MA, USA) and data
were analyzed using Guava InCyte software (Millipore).
2.7. Macrophage cholesterol efﬂux
The efﬂux of stored cholesteryl esters from acetylated LDL-
challenged macrophages was performed as described previously [25].
Brieﬂy, human LDL was radiolabeled by incubating with cholesterol
ester transfer protein and [3H]cholesteryl ester-containing liposomes
and then subsequently acetylated in the presence of acetic anhydride
and saturated concentrations of sodium acetate. The macrophages
were incubated with 50 μg/ml [3H]cholesteryl ester-containing acety-
lated LDL overnight, equilibrated with serum-free media for 6 h, prior
to incubation with 25 μg/ml human HDL, 10 μg/ml apoA-I, or 10 μg/ml
recombinant apoE3 for 16 h to induce cholesterol efﬂux. The amount
of [3H]cholesterol transferred to the cholesterol acceptors was deter-
mined by measuring the amount of radioactivity in the media. Cellular
[3H]cholesterol was quantiﬁed in each well following extraction of cel-
lular lipids with hexane:isopropanol (3:2, v:v). The cholesterol efﬂux
results are reported as the radioactivity in the media as a percentage
of total radioactivity in each well.
2.8. Flow cytometry analysis of apoptotic cells
Cells were incubated overnight in the presence or absence of
500 μg/ml copper-oxidized human LDL. Following incubation, the
cells were gently removed from the plate and Annexin-V and propidium
iodide staining was performed using the Annexin-V-APC Apoptosis
Detection Kit (eBioscience, San Diego, CA, USA). Flow cytometryFig. 4.ActivatedAkt protein levels in control and apoER2deﬁcientmacrophages. Immuno-
blots of protein extracts from non-transduced control RAW264.7 (black bars, +) and Lrp8
knockdown RAW264.7 cells (white bars,−). Following serum starvation, cells were incu-
bated with fresh media containing 10% FBS for 0, 0.5, and 24 h. Analysis of Akt activation
was performed using antibodies targeting Akt phosphorylated at serine 473 (P-Akt).
Data are normalized to the tubulin loading control. Inset shows representative immuno-
blots and the mean ± SEM from n= 8 or 9 is shown in the graph. * denotes P b 0.05 dif-
ference from non-transduced control cells.analysiswas performedusing aGuava easyCyte™8HT system(Millipore)
and data were analyzed using Guava InCyte software (Millipore). In
selected experiments, CD36 blockage was achieved using the mouse
monoclonal anti-CD36 IgG (clone FA6.152, Beckman Coulter) as de-
scribed previously [26]. Macrophages were pre-incubated with the
anti-CD36 IgG or amousemonoclonal IgG1 isotype control (Cell Signal-
ing) for 1 h prior to the addition of copper-oxidized LDL.
2.9. Transient knockdown of PPARγ in RAW264.7 cells
RAW 264.7 cells were transiently transfected with Silencer Select
small interfering RNA (siRNA) speciﬁcally targeting mouse PPARγ
(gene name: Pparg) or the non-targeting negative ctornol No. 2 siRNA
(Life Technologies). The sequences of the Pparg targeting siRNA are:
sense 5′-GGGCGAUCUUGACAGGAAtt-3′ and antisense 5′-UUUCCUGU
CAAGAUCGCCCte-3′. The siRNA was transfected into the cells by
Nucleofector™ using Amaxa Cell Line Nucleofector™ Kit V (Lonza)
according to the manufacturer's instructions. Following transfection,
cells were incubated in RPMI-1640medium (Thermo Scientiﬁc) con-
taining 10% endotoxin-free FBS, 100 units/ml penicillin–100 μg/ml
streptomycin solution (Thermo Scientiﬁc), and 2 mM L-glutamine
at 37 °C and 5% CO2 for 48 h prior to analysis.
2.10. Atherosclerotic lesion analysis
The Lrp8−/−micewere previously generated in amixed genetic back-
ground of C57BL/6 and 129sv (16). The Lrp8−/−mice were backcrossed
with C57BL/6J (Jackson Laboratories) mice for 10 generations to produce
Lrp8−/−mice on a congenic C57BL/6 background. Female Lrp8−/−mice
on a congenic C57BL/6 background were also bred with male Ldlr−/−
mice on the same background (Jackson laboratories) to obtain Lrp8+/−
Ldlr+/− offsprings, which were then mated to obtain Lrp8+/+Ldlr−/−
and Lrp8−/−Ldlr−/− littermates. Age-matched male mice on congenic
C57BL/6 backgroundwere used for all experiments.Micewere fed a stan-
dard rodent chow diet and were maintained in a speciﬁc pathogen-free
environment on a 12 h light/dark cycle. For atherosclerosis studies,
mice were fed a high fat (21.2% byweight, 42% kcal) and high cholesterol
(0.15% byweight)Western-type diet (TD88137; Harlan Teklad, Madison,
WI, USA) for 24 weeks. All procedures and animal care was approved by
theUniversity of Cincinnati Institutional Animal Care andUse Committee.Fig. 5. Phosphorylation of p53 in control and apoER2-deﬁcient macrophages. Immuno-
blots of protein extracts from non-transduced control (Con, black bar) RAW264.7 cells
or RAW264.7 cells transduced with an empty vector (EV, gray bar) or Lrp8 shRNA (KD,
white bar) after 24 h incubation in standard culture medium. Analysis of p53 was
performed using antibodies against serine-15 phosphorylated p53 and total p53 and
normalized to tubulin loading control. Inset shows representative immunoblots and the
data represent mean ± SEM from n = 9 (EV group) or n = 6 (Control and KD groups)
experiments. * and † denote P b 0.05 differences from non-transduced and empty
vector-transduced RAW 264.7 cells, respectively.
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cedure as previously described [27,28]. Brieﬂy, mice were anesthetized
and perfused with PBS for 5 min followed by a 5 min perfusion with 4%
paraformaldehyde. Following dissection, the upper half of the heart and
the proximal aorta were stored in 4% paraformaldehyde for 2 days.
Tissues were cryopreserved in 30% sucrose at 4 °C for 2 days prior to
being embedded in OCT compound for frozen section preparation. Cryo-
sections of 5-μm thickness through the aortic valve region of the aortic
root were stainedwith Oil Red O tomeasure neutral lipid accumulation.
Serial sections were also stained with Sirius Red to identify collagen
deposition. The necrotic core area was measured as the hematoxylin
and eosin-negative regions in the intima. TUNEL staining was per-
formed according to manufacturer's instruction with the In Situ Cell
Death Detection Kit (Roche) containing ﬂuorescein-conjugated dUTPs.
The p53 and PPARγ antigens were detected in aortic sections by immu-
noﬂuorescent staining with anti-p53 (Cell Signaling Technology) and
anti-PPARγ (Abcam, Cambridge, MA, USA) primary antibodies followed
by secondary antibodies conjugated to Alexa594 (Invitrogen). The CD68
antigen was detected in the double stained sections with anti-CD68
(Abcam) and anti-rat secondary antibodies conjugated to Alexa488.
All of the immunoﬂuorescence sections and the TUNEL-stained sections
were counterstained with 4,6-diamidino-2-phenylindole (DAPI). Im-
ageswere obtainedwith anOlympus BX61microscope and quantitative
analysis of lesion areas in digitalized images was performed using
ImageJ software (NIH).Fig. 6. PPARγ expression and activation in control and apoER2 deﬁcientmacrophages. (A) The P
bars), empty vector (gray bars), and Lrp8 knockdown (white bars) RAW264.7 cells after 24 h in
binding protein (TBP), respectively. Inset shows representative immunoblots of nuclear protei
relative to Gapdh in non-transduced control (black bars), empty vector (gray bars), and Lrp8 sh
vector protein n= 9, RAW 264.7 non-transduced control and knockdown protein n= 6. Data
denotes P b 0.05 difference from empty vector cells.2.11. Plasma cholesterol measurements
Blood was collected from mice via tail bleed in EDTA-coated
Microvette® CB 300 capillary tubes (Sarstedt) after a 16 h overnight
fast. Following separation by centrifugation, the plasma was removed
and cholesterol levels were measured using Inﬁnity™ Total Cholesterol
Reagent (Thermo-Scientiﬁc).
2.12. Statistical analysis
Statistical analysis was performed using SigmaPlot (SysStat Soft-
ware, San Jose, CA, USA). Values were expressed as mean ± standard
error (SEM). A two-tailed Student's t-test was used when paired com-
parisons were made. A one-way ANOVA with Holm–Sidak post-hoc
analysis was used when multiple comparisons were made. Statistical
signiﬁcance was determined as differences with P ≤ 0.05.
3. Results
3.1. Generation of ApoER2 deﬁcient mouse macrophages
Quantitative real-time PCR (qPCR) analysis of cellular RNA isolated
from peritoneal macrophages of C57BL/6 mice conﬁrmed the expres-
sion of apoER2 in macrophages (Fig. 1A). The speciﬁcity of the qPCR
reaction was veriﬁed by the lack of detectable qPCR product whenparg (PPARγ)mRNA andnuclear PPARγ1/2 protein levels in non-transduced control (black
cubation in standard culture conditions. Data were normalized to GapdhmRNA and TATA-
ns from RAW 264.7 cells. (B) mRNA levels of the PPARγ-responsive genes Lrp1 and Abca1
RNA transduced (open bars) RAW 264.7 cells. mRNA n= 9 per group, RAW 264.7 empty
represent mean ± SEM. * denotes P b 0.05 difference from non-transduced control, and †
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−/− mice was used as template (Fig. 1A). Interestingly, the Lrp8−/−
peritoneal macrophages displayed dramatically reduced viability
in vitrowhich reached as low as a 65% reduction in the number of viable
Lrp8−/− cells compared to Lrp8+/+ cells after 3 days in culture. The dif-
ﬁculty inmaintaining apoER2-defective peritonealmacrophages in cul-
ture precluded their use to assess the role of apoER2 in macrophage
functions. Fortunately, apoER2 was found to be present in mouse
RAW264.7macrophages and its knockdownwith shRNA led to a signif-
icant decrease in both Lrp8mRNA (Fig. 1A) and apoER2 protein levels
(Fig. 1B) while maintaining cell viability in culture.3.2. ApoER2 deﬁcient macrophages accumulate more intracellular lipids
and are more susceptible to oxidized LDL-induced cell death
One function of macrophages is the scavenging of lipids, particularly
those derived from oxLDL, during atherogenesis. Therefore, we set out
to determine the impact of apoER2 deﬁciency on neutral lipid accumu-
lation in RAW 264.7 macrophages. The apoER2-deﬁcient RAW 264.7
macrophages showed more neutral lipid accumulation compared to
control RAW 264.7 cells under basal conditions (Fig. 2A). Importantly,
the apoER2-deﬁcient RAW 267.4 cells also accumulated more neutral
lipids following treatment with oxidized LDL (oxLDL) (Fig. 2A). The
uptake of oxLDL by macrophages is regulated by scavenger receptors.
Interestingly, we observed higher CD36 mRNA level in the apoER2-
deﬁcient macrophages, but no difference in Lox (gene name: Olr1)
mRNA (Fig. 2B). A signiﬁcant higher level of mRNA for scavenger recep-
tor A (gene name: Msr1) was also observed in the apoER2-deﬁcient
macrophages compared to the non-transduced control cells, but a
similar increase was observed in macrophages transduced with the
empty vector, suggesting that theMsr1mRNA increase was a result of
viral vector transduction. Furthermore, we did not observe any alter-
ations in the ability of apoER2-deﬁcient macrophages to efﬂux choles-
terol to HDL, apoA-I or apoE (Fig. 2C). Taken together, these dataFig. 7. Effects of PPARγ and CD36 inhibition on macrophage viability. (A) Non-transduced RAW
transiently transfected with non-targeting control siRNA (NT, black bars) or siRNA targeting PP
bodies against total or serine-15 phosphorylated forms of p53. Data are normalized to tubulin l
resentative immunoblots. (B) The RAW264.7 cells were incubated with 20 μg/ml anti-CD36 (
250 μg/ml oxLDL. The cells were stained with APC-conjugated Annexin-V and propidium iodi
a percentage of cells that were negative or positive for Annexin-V and propidium iodide stainin
letters in the bars denote P b 0.05 differences.suggest that the apoER2-deﬁcient macrophages accumulate more
neutral lipids due to increased uptake of exogenous lipids.
In addition to causing lipid accumulation, oxLDL also promotes
macrophage cell death [29,30]. Therefore,we also compared the suscep-
tibility of control and apoER2-deﬁcient RAW 264.7 macrophages to
oxLDL-induced cell death. The macrophages were incubated overnight
in the presence or absence of oxLDL and cell death was assessed
by ﬂow cytometry based on the percentage of cells with positive
Annexin-V and propidium iodide (PI) staining. Results showed a signif-
icant increase in the percentage of dead cells in the apoER2-deﬁcient
cell population compared to the control cells following overnight incu-
bation with oxLDL (Fig. 3). Moreover, while there was no signiﬁcant
difference in the percentage of dead cells (Annexin-V+, PI+) between
control and apoER2-deﬁcient cells when cultured under basal condi-
tions without oxLDL treatment (Fig. 3), an increase in the percentage
of apoER2-deﬁcient cells undergoing early apoptosis (Annexin-V+,
PI−) compared to control cellswas observed in the presence or absence
of oxLDL. Thus, the defective apoER2 expression in macrophages in-
duced cell stress and enhanced their susceptibility to oxLDL-induced
cell death.3.3. ApoER2 deﬁciency promotes pro-apoptotic cell signaling inmacrophages
The next series of experiments examined the mechanism by which
apoER2 deﬁciency enhances the susceptibility of macrophages to
oxLDL-induced cell death. In these experiments, we compared the
expression and activation of apoptosis-related proteins in control
and apoER2-deﬁcient RAW 264.7 macrophages. Immunoblotting per-
formed with whole cell lysates from these cells showed that serum-
induced activation of the pro-survival protein Akt was reduced signiﬁ-
cantly in the Lrp8-inactivated cells compared to control cells following
a 30 min incubation period (Fig. 4). Additionally, a signiﬁcantly
higher level of p53 phosphorylation was also detected in the apoER2-
deﬁcient cells compared to control cells (Fig. 5).264.7 cells (Con) and cells transduced with empty vector (EV) or Lrp8shRNA (KD) were
ARγ (white bars). Analysis of p53 levels and phosphorylation was performed using anti-
oading control prior to normalization of phosphorylated p53 to total p53. Inset shows rep-
white bars) or isotype control IgG (black bars) for 1 h prior to overnight incubation with
de for ﬂow cytometry analysis. The percentage of viable and dead cells was calculated as
g, respectively. The data are reported as mean ± SEM from n= 3 per group and different
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absence of ApoER2
One mechanism that leads to p53 phosphorylation and stabilization
is through activation of the nuclear receptor peroxisome proliferator-
activated receptor γ (PPARγ) [31-36]. Analysis of PPARγmRNA levels
by qPCR showed elevated PPARγ-encoding PpargmRNA expression in
apoER2-deﬁcient RAW 264.7 cells compared to control cells (Fig. 6A).
Western blot analysis of nuclear extracts from these cells revealed
an 82-fold increase of PPARγ2 and a 13-fold increase of PPARγ1 in
the nucleus of apoER2-deﬁcient macrophages (Fig. 6A). The increased
presence of PPARγ-1/2 in the nucleus of apoER2-deﬁcient RAW
264.7 macrophages also resulted in elevated mRNA levels of PPARγ-
responsive genes such as Cd36, Lrp1, and Abca1 in comparison to the
levels observed in control cells (Figs. 2B and 6B). Taken together,
these results suggested that the aberrant up-regulation of PPARγ
expression may be responsible for the increased susceptibility of
apoER2-deﬁcient macrophages to stimulant-induced cell death.
3.5. Inhibition of PPARγ, but not CD36, partially rescues the ApoER2-
deﬁcient macrophage phenotype
The relationship between elevated PPARγ expressionwith the sensi-
tivity of the apoER2-deﬁcient macrophage to cell death was assessed by
transient knockdown of PPARγ in the macrophages with siRNA. The
knockdown of PPARγ resulted in a signiﬁcant reduction in the phos-
phorylation of p53 in the apoER2-deﬁcient macrophages compared toFig. 8.Atherosclerotic lesion development in Ldlr−/−micewith or without apoER2 expression. A
mice were fed a high fat and high cholesterol Western-type diet for 24 weeks. (A) Representati
stainedwith Oil Red O or Sirius Red, or labeledwith ﬂuorescent antibodies against CD68 (red, D
bars represent 100 μm. (B) Morphometric analysis of the aortic root atherosclerotic lesion sizes
necrotic core area (necrotic) in the aortic root lesions ofmice following 24 weeks on aWestern d
ECM n= 4, lipid n= 7, necrotic n= 7, TUNEL n= 3–4, and CD68, n= 4 per group. Mean ±cells transfected with control siRNA (Fig. 7A). Since the PPARγ-
responsive gene CD36was up-regulated in the apoER2-deﬁcientmacro-
phages, which likely resulted in the increased neutral lipid accumulation
observed in these cells, we also determined if inhibiting CD36-mediated
oxLDL uptake also desensitized the apoER2-deﬁcient macrophages to
oxLDL-induced cell death. Interestingly, we found that pre-treatment
of the macrophages with a CD36 blocking antibody did not have any
effect on the number of viable (Annexin-V−, PI−) or dead (Annexin-
V+, PI+) macrophages in the presence or absence of oxLDL (Fig. 7B).
Taken together, these data suggest that the increased sensitivity of
apoER2-deﬁceint macrophages to oxLDL-induced cell death is due to
elevated PPARγ expression and its induction of p53 phosphorylation,
and that this mechanism is independent of PPARγ-induced CD36
expression.
3.6. Inactivation of Lrp8 in hypercholesterolemic mice enhances atheroscle-
rotic plaque complexity and necrosis
The physiological signiﬁcance of increased oxLDL-induced lipid
accumulation and cell death of Lrp8−/−macrophages toward athero-
sclerosis was queried by analyzing the composition of atherosclerotic
plaques in hypercholesterolemic Ldlr−/− mice with or without Lrp8
gene deletion. For these experiments, Lrp8+/+Ldlr−/− and Lrp8−/−
Ldlr−/− mice were fed a Western type diet for 24 weeks. Marked
hypercholesterolemia occurred in all Ldlr−/−mice, but no difference
in plasma cholesterol levels was observed between Lrp8+/+Ldlr−/−
and Lrp8−/−Ldlr−/− mice (1,617 ± 94 vs. 1,672 ± 61 mg/dl, n = 10).ge-matchedmale Lrp8+/+Ldlr−/− (Con, black bars), and Lrp8−/− Ldlr−/− (KO,white bars)
ve photomicrographs of aortic root lesions from Lrp8+/+Ldlr−/− and Lrp8−/− Ldlr−/−mice
API counterstain is blue) or ﬂuorescent TUNEL (green, DAPI counterstain is red). The scale
. (C) Morphometric analysis of extracellular matrix area (ECM), lipid-rich area (lipid), and
iet. Data are expressed as ratios of compositional area to total lesion size. Lesion size n=6,
SEM. * denotes P ≤ 0.05 difference from Lrp8+/+Ldlr−/−mice.
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roots of these animals also showed similar lesion sizes between
Lrp8+/+Ldlr−/− and Lrp8−/−Ldlr−/−mice (Fig. 8). Interestingly, exten-
sive necrosiswas detected in the lesions of Lrp8−/−Ldlr−/−micewhere-
asminimal necrosis was detected in Lrp8+/+Ldlr−/−mice. Additionally,
increased TUNEL-positive area that colocalized with CD68-positive
staining was detected in the lesions of Lrp8−/−Ldlr−/−mice compared
to that observed in Lrp8+/+Ldlr−/−mice. Morphometric quantiﬁcation
of the lesions revealed that the Lrp8−/−Ldlr−/− lesions contained signif-
icantly more extracellular matrix components, necrotic materials, and
TUNEL-positive macrophages, but less lipid-rich area (Fig. 8).
The characteristics responsible for the increased necrosis in lesion
areas of Lrp8−/−Ldlr−/−mice were further examined by immunoﬂuo-
rescence microscopy. Signiﬁcantly more p53 positive immunoﬂuores-
cence was observed near the edges of the expanding atherosclerotic
plaque in Lrp8−/−Ldlr−/− mice compared to that in Lrp8+/+Ldlr−/−
mice (Fig. 9A). These p53-positive cells co-localized with CD68-
positive macrophages (Fig. 9A). The CD68-positive macrophages near
the edges of the expanding plaque of Lrp8−/−Ldlr−/−mice also showed
increased PPARγ-positive macrophages compared to that observed in
Lrp8+/+Ldlr−/−mice (Fig. 9B). Since previous studies have shown that
sustained macrophage apoptosis occurring at the edge of the athero-
sclerotic lesions contributes to plaque necrosis, with the necrotic core
resulting from gradual apoptotic cell accumulation that becomes
secondarily necrotic [37], these observations are consistent with ourFig. 9. Immunoﬂuorescent staining of p53- and PPARγ-macrophages in Ldlr−/−mice with or
graphs and morphometric analyses of aortic root lesions from Lrp8+/+Ldlr−/− (Con, black bars
(A) p53 (red) or (B) PPARγ. The sections were co-stained with CD68 antibodies (blue), and
positive areas in the aortic root lesions expressed as ratios of positively-stained area to tota
P b 0.05 difference from Lrp8+/+Ldlr−/−mice.in vitro observations of increased apoER2-defective macrophages with
elevated expression of PPARγ and p53 may be responsible for the ele-
vated necrosis observed in atherosclerotic lesions of Lrp8−/−Ldlr−/−
mice.
4. Discussion
The current study showed that Lrp8 gene inactivation inmice has no
impact on plasma cholesterol levels, but inﬂuences atherosclerosis by
regulating functions of cells involved with atherosclerosis. Previous
studies have indicated that apoER2 expressed in platelets and endothe-
lial cells modulates leukocyte–endothelial cell adhesion, nitric oxide
synthesis, and thrombosis. The current study showed that apoER2
expression in macrophages also modulates atherosclerosis by limiting
oxLDL-induced lipid accumulation and cell death. Indeed, hypercholes-
terolemic Ldlr−/−mice with defective apoER2 displayed advanced ath-
erosclerotic lesions with necrotic cores. The co-localization of the
apoptotic markers TUNEL and p53 with the macrophage marker CD68
in the atherosclerotic plaques of Lrp8−/−Ldlr−/− mice is consistent
with the interpretation that the advanced necrotic plaque is derived
from macrophage cell death.
The role of apoER2 in preserving cell viability has been documented
previously in several cell types under both in vitro and in vivo conditions.
For example, apoER2 has been shown to control neuronal survival in
adult brain and its inactivation results in accelerated age-dependentwithout apoER2 expression after 24 weeks on Western diet. Representative photomicro-
) and Lrp8−/− Ldlr−/− (KO, white bars) mice with immunoﬂuorescent antibodies against
counterstained with DAPI (green). Morphometric analyses of p53-positive and PPARγ-
l lesion size. The scale bars represent 100 μm. n=6 per group. Mean± SEM. * denotes
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also demonstrated by studies showing that reduced Lrp8mRNA abun-
dance associated with increased neurodegeneration in mice with
Niemann–Pick type C 1 gene inactivation when compared to wild type
controls [38], and the knockdown of Lrp8 in primary neurons reversed
the anti-apoptotic effect of proprotein convertase subtilisin/kexin
type 9 (Pcsk9) deﬁciency [39]. Interestingly, Pcsk9 has also been
shown to regulate apoptosis in apoER2-expressing human umbilical
vein endothelial cells suggesting that apoER2 may have a similar func-
tion in vascular cells [40]. Themechanismunderlying the cytoprotective
properties of apoER2 appears to be related to its cell signalingproperties
including ligand binding-induced phosphorylation of the adaptor
protein Dab-1 with subsequent activation of Akt [18,41]. In the current
study, we showed that apoER2 deﬁciency in macrophages also resulted
in defective Akt activation, up-regulation of pro-apoptotic protein p53
phosphorylation, and enhanced susceptibility of the macrophages to
stress-induced death in vitro and in vivo. Taken together, these data
suggest that apoER2 has a pro-survival function in macrophages and
protects against oxLDL-induced apoptosis via activation of the pro-
survival protein Akt.
Macrophage apoptosis and cell death due to defective Akt activation
with p53 and cathepsin L accumulation are also PPARγ-regulated
processes [33,35,36]. Indeed, elevated nuclear PPARγ levels and mRNA
expression were observed in apoER2-deﬁcient macrophages. The
apoER2-deﬁcient macrophages also exhibited robust expression of
Cd36, another PPARγ-responsive gene that is known to promote ath-
erosclerosis [42,43]. Thus, apoER2 deﬁciency-induced PPARγ activa-
tion in macrophages results in enhanced oxLDL-induced cytotoxicity
which likely promotes the formation of more advanced atheroscle-
rotic lesions. However, it is important to note that PPARγ activation
in macrophages has been reported to have anti-atherosclerosis proper-
ties including the suppression of C–C chemokine receptor-2 expression
and activation of cholesterol efﬂux [44,45]. In fact, the activation of
PPARγ by pharmacological agents or macrophage-speciﬁc Mal1 gene
deletion has also been shown to reduce atherosclerosis in Ldlr−/−
mice [46,47]. The apparent discrepancy may be due to the time when
atherosclerotic lesions were assessed and the methodology used to
assess atherosclerosis advancement. The earlier studies examined ath-
erosclerosis after feeding the Western type diet for 10 to 14 weeks,
and atherosclerosis progression was determined based on lesion size
at the aortic roots without detailed characterization of lesion composi-
tion. In order to examine the advanced stages of atherosclerosis it is
likely necessary for mice to be maintained on a Western type diet for
longer than 10 to 14 weeks. Therefore, we assessed lesion composition
after 24 weeks on Western diet and showed that apoER2 deletion
promotes atherosclerotic plaque necrosis and PPARγ co-localizes with
CD68-positive macrophages in the edges of the expanding plaque
where apoptosis occurs. Taken together, this suggests that PPARγ in-
duction may have a biphasic inﬂuence in atherosclerosis progression
with the potentially beneﬁcial effects at earlier time points offset by
the detrimental effects on lesion necrosis at later phases of atheroscle-
rosis. This interpretation is consistent with reports showing similar
biphasic effects of the PPARγ agonist pioglitazone on atherosclerosis
in Ldlr−/−mice [48].
In summary, this study has focused on the role of apoER2 in mod-
ulating macrophage functions and viability. Our data showed that
apoER2 expression in macrophages reduces stress-induced cell death
whichmay potentially retard the development of advanced atheroscle-
rotic plaques in vivo. Additionally, it is important to note that ligand
ligation of apoER2 may also reduce atherosclerosis by suppressing the
inﬂammatory functions of macrophages. This possibility, along with
the mechanism underlying apoER2 modulation of PPARγ activation, is
under investigation. Regardless, the observation of sustained PPARγ
activation leading to enhanced lipid accumulation in macrophages
and reducing macrophage viability points to another mechanism
contributing to the potential adverse effects of PPARγ agonists oncardiovascular diseases [49–51]. Importantly, our data also suggest
that LRP8 gene polymorphismmay be a geneticmodiﬁer in determining
the risk of cardiovascular events associatedwith PPARγ agonist therapy.
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